Tag: Pancreas
Search News
Fellows inaugurated at new Rutherford Academy of Population Genomics and Health Data Science
16th May 2018
Queen Mary University of London has appointed four research fellows to its new Rutherford Academy of Population Genomics and Health Data Science, funded by the Medical Research Council and UK Research and Innovation’s Rutherford Fund. Two of the fellows include BCI’s Dr Kit Curtius and Dr Dayem Ullah.
Read more
London Pancreas Workshop 2018
11th May 2018
On Friday 4th May, BCI hosted the seventh London Pancreas Workshop, co-organised by Prof Hemant Kocher and our Director Prof Nick Lemoine, which attracted delegates from across Europe and America, with over 140 attendees in total. The biennial event is recognised as a forum for state-of-the-art clinical and basic research in pancreatic cancer.
Read more
UK charities join forces to fund the work of Dr Angus Cameron
5th April 2018
BCI’s Dr Angus Cameron, Centre for Tumour Biology, is to receive joint funding from Worldwide Cancer Research and Pancreatic Cancer Research Fund (PCRF) to support vital research on pancreatic cancer. The charities have awarded equal sums totalling £235,000 to support the work of Dr Cameron and his laboratory group.
Read more
Staying connected: New developments for tissue banking bioinformatics
1st February 2018
A team of researchers at the Barts Cancer Institute (BCI) of Queen Mary University of London have developed new analytical tools to aid in the analysis of tissue bank (TB) samples, which are an extremely valuable resource for scientists.
Read more
Researchers use flu-like virus to attack pancreatic cancer
25th January 2018
A flu-like virus has now been used in experiments to successfully inhibit the growth of pancreatic cancer, according to an early study by researchers at the Barts Cancer Institute (BCI) of Queen Mary University of London (QMUL).
Read more
Steps towards the development of a new immunotherapy for pancreatic cancer
23rd January 2018
A research team led by Professor Yaohe Wang at the Barts Cancer Institute (BCI) of Queen Mary University of London (QMUL) has created a novel oncolytic viral agent expressing interleukin-12 (IL-12) that shows promise as a potential anti-tumour immunotherapy for the treatment of pancreatic cancer.
Read more